Groep Brussel Lambert NV
F:EAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
|
C
|
Cue Biopharma Inc
F:1UC
|
US |
|
C
|
Conocophillips
XMUN:YCP
|
US |
|
I
|
International Paper Co
LSE:0JCB
|
US |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
C
|
CVB Financial Corp
F:BCV
|
US |
|
E
|
Equifax Inc
F:EFX
|
US |
|
C
|
China Literature Ltd
F:C2X
|
CN |
|
Mitsui O.S.K. Lines Ltd
TSE:9104
|
JP |
|
P
|
PPG Industries Inc
XMUN:PPQ
|
US |
|
N
|
NVIDIA Corp
XMUN:NVD
|
US |
Wall St Price Targets
EAI Price Targets Summary
Groep Brussel Lambert NV
According to Wall Street analysts, the average 1-year price target for EAI is 86.22 EUR with a low forecast of 71.25 EUR and a high forecast of 96.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EAI's stock price target?
Price Target
86.22
EUR
According to Wall Street analysts, the average 1-year price target for EAI is 86.22 EUR with a low forecast of 71.25 EUR and a high forecast of 96.84 EUR.
What is the Revenue forecast for Groep Brussel Lambert NV?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Groep Brussel Lambert NV?
Projected CAGR
79%
Over the last 14 years, the compound annual growth rate for Operating Income has been -6%. The projected CAGR for the next 2 years is 79%.
